World Journal of Emergency Surgery · 2022 · 40 citations · 24 references
Veterinary MedicineSurgeryImmunopathologyInflammationSepsisAntimicrobial TherapyIntensive Care MedicineNecrosisSepsis ManagementHyperbaric InterventionIn-hospital MortalityIntensive Care UseMortality Rate AssessmentNecrotizing FasciitisNecrotizing InfectionsNecrotizing Soft Tissue InfectionsSurvival Rates
BACKGROUND: Necrotizing soft tissue infections (NSTI) require immediate radical debridement, broad-spectrum antibiotics and intensive care. Hyperbaric oxygen therapy (HBOT) may be performed adjunctively, but unequivocal evidence for its benefits is still lacking. METHODS: We performed a retrospective single-center study including 192 patients with necrotizing fasciitis or Fournier's gangrene to assess in-hospital mortality and outcome dependent on patient, disease and treatment characteristics with or without HBOT. RESULTS: The in-hospital mortality rate was 27.6%. Factors associated with increased mortality according to multivariate analysis were higher age, affection of multiple or problem localizations (odds ratio (OR) = 2.88, P = 0.003), ineligibility for HBOT despite clinical indication (OR = 8.59, P = 0.005), pathogens in blood cultures (OR = 3.36, P = 0.002), complications (OR = 10.35, P < 0.001) and sepsis/organ dysfunction (OR = 19.58, P < 0.001). Factors associated with better survival included vacuum-assisted wound closure (OR = 0.17, P < 0.001), larger number of debridements (OR = 0.83, P < 0.001) and defect closure with mesh graft (OR = 0.06, P < 0.001) or flap (OR = 0.09, P = 0.024). When participants were stratified into subgroups without requirement of HBOT (n = 98), treated with HBOT (n = 83) and ineligible for HBOT due to contraindications (n = 11), the first two groups had similar survival rates (75.5% vs. 73.5%) and comparable outcome, although patients with HBOT suffered from more severe NSTI, reflected by more frequent affection of multiple localizations (P < 0.001), sepsis at admission (P < 0.001) and intensive care treatment (P < 0.001), more debridements (P < 0.001) and a larger number of antibiotics (P = 0.001). In the subgroup ineligible for HBOT, survival was significantly worse (36.4%, P = 0.022). CONCLUSION: These results point to a benefit from HBOT for treatment of NSTI in critically ill patients.
24
Hyperbaric oxygen therapy for necrotizing fasciitis reduces mortality and the need for debridements.
Jay Riseman, W. A. Zamboni, Anne B. Curtis et al. · PubMed · 1990 · 411 citations
Necrotizing fasciitis: An indication for hyperbaric oxygenation therapy?
Avi Shupak, Oren Shoshani, Ilan Goldenberg et al. · Surgery · 1995 · 170 citations